Lisa Miller | executive |
Richard Hawkins | executive |
John McKew | executive |
Lori Lawley | executive |
Charles Duncan | analyst |
David Karpf | executive |
Yasmeen Rahimi | analyst |
Edward White | analyst |
Catherine Novack | analyst |
Eun Yang | analyst |
Elemer Piros | analyst |
Good morning, and welcome to Lumos Pharma's interim data update conference call. [Operator Instructions] As a reminder, this conference call is being recorded. I will now turn the call over to Lisa Miller, Senior Director of Investor Relations. Please go ahead, ma'am.
Thank you, operator.
Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under U.S.